 Connection
Rangaswamy Govindarajan to Adult
This is a "connection" page, showing publications Rangaswamy Govindarajan has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.168 |
|
|
|
-
Govindarajan R, Gujja S, Siegel ER, Batra A, Saeed A, Lai K, James JD, Fogel BJ, Williamson S. Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer. Am J Clin Oncol. 2018 07; 41(7):638-642.
Score: 0.058
-
Prasad HK, Govindarajan R. Heparin-induced skin necrosis associated with thrombocytopenia and acquired protein C and protein S deficiency. Am J Hematol. 2007 Dec; 82(12):1116-7.
Score: 0.028
-
Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, Kim PJ, Owens RJ, Lang NP. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol. 2007 Apr 20; 25(12):1476-81.
Score: 0.027
-
Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003 Jan 15; 97(2):493-8.
Score: 0.020
-
Govindarajan R. Irinotecan/thalidomide in metastatic colorectal cancer. Oncology (Williston Park). 2002 Apr; 16(4 Suppl 3):23-6.
Score: 0.019
-
Algazi AP, Othus M, Daud AI, Lo RS, Mehnert JM, Truong TG, Conry R, Kendra K, Doolittle GC, Clark JI, Messino MJ, Moore DF, Lao C, Faller BA, Govindarajan R, Harker-Murray A, Dreisbach L, Moon J, Grossmann KF, Ribas A. Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Nat Med. 2020 10; 26(10):1564-1568.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|